Craig Rodgers

770 total citations
30 papers, 554 citations indexed

About

Craig Rodgers is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Craig Rodgers has authored 30 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 9 papers in Infectious Diseases and 5 papers in Surgery. Recurrent topics in Craig Rodgers's work include Tuberculosis Research and Epidemiology (6 papers), HIV, Drug Use, Sexual Risk (6 papers) and Substance Abuse Treatment and Outcomes (5 papers). Craig Rodgers is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), HIV, Drug Use, Sexual Risk (6 papers) and Substance Abuse Treatment and Outcomes (5 papers). Craig Rodgers collaborates with scholars based in Australia, United Kingdom and New Zealand. Craig Rodgers's co-authors include Ingrid van Beek, J.F.T. Griffin, C.G. Mackintosh, Lisa Maher, Carolyn Day, Libby Topp, Rebecca McKetin, James Shearer, Alex Wodak and Shane Darke and has published in prestigious journals such as PLoS ONE, Psychopharmacology and Addiction.

In The Last Decade

Craig Rodgers

27 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Craig Rodgers Australia 12 304 211 109 79 62 30 554
Allen McCutchan United States 17 348 1.1× 542 2.6× 22 0.2× 248 3.1× 180 2.9× 27 1.2k
Reena H. Doshi United States 17 398 1.3× 226 1.1× 30 0.3× 53 0.7× 71 1.1× 51 843
Lin Pang China 14 401 1.3× 294 1.4× 8 0.1× 62 0.8× 23 0.4× 34 650
Pasquale Noto Italy 13 266 0.9× 658 3.1× 11 0.1× 113 1.4× 14 0.2× 25 1.0k
Merimaaria Espo Finland 6 98 0.3× 157 0.7× 15 0.1× 62 0.8× 30 0.5× 6 639
Margareta Eriksson Sweden 12 150 0.5× 216 1.0× 11 0.1× 40 0.5× 15 0.2× 24 624
Matthew Onorato United States 12 115 0.4× 426 2.0× 16 0.1× 15 0.2× 102 1.6× 15 891
A. Vaglia Italy 15 248 0.8× 370 1.8× 22 0.2× 20 0.3× 14 0.2× 25 725
Jonathan Worth United States 11 238 0.8× 453 2.1× 37 0.3× 156 2.0× 113 1.8× 16 912
Des Jarlais United States 8 482 1.6× 343 1.6× 33 0.3× 111 1.4× 12 0.2× 14 681

Countries citing papers authored by Craig Rodgers

Since Specialization
Citations

This map shows the geographic impact of Craig Rodgers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Rodgers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Rodgers more than expected).

Fields of papers citing papers by Craig Rodgers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Rodgers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Rodgers. The network helps show where Craig Rodgers may publish in the future.

Co-authorship network of co-authors of Craig Rodgers

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Rodgers. A scholar is included among the top collaborators of Craig Rodgers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Rodgers. Craig Rodgers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ritter, Alison, James Bell, John Strang, et al.. (2025). Bridging the evidence and the politics: Implementation trial of supervised injectable opioid treatment (SIOT) in Australia. International Journal of Drug Policy. 138. 104749–104749.
2.
Gordon, Christopher J., Rebecca McKetin, Jonathan Brett, et al.. (2024). Measuring Objective and Subjective Sleep during Lisdexamfetamine Treatment of Acute Methamphetamine Withdrawal: A Feasibility Study. European Addiction Research. 30(2). 121–125.
3.
Farrell, Michael, Jeyran Shahbazi, Marianne Byrne, et al.. (2024). 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial. International Journal of Drug Policy. 127. 104390–104390. 4 indexed citations
4.
McKetin, Rebecca, Nicholas Lintzeris, Adrian Dunlop, et al.. (2024). Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention. International Journal of Drug Policy. 126. 104383–104383.
5.
6.
Ezard, Nadine, Nicholas Lintzeris, Adrian Dunlop, et al.. (2022). Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal. PLoS ONE. 17(10). e0275371–e0275371. 4 indexed citations
7.
Ezard, Nadine, Nicholas Lintzeris, Adrian Dunlop, et al.. (2022). Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial. Drug and Alcohol Dependence. 241. 109692–109692. 10 indexed citations
8.
Siefried, Krista J., et al.. (2022). Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review. Psychopharmacology. 240(1). 127–135. 8 indexed citations
9.
Ezard, Nadine, Beatrice Webb, Toby Lea, et al.. (2018). Substance Use and Sex Index (SUSI): First stage development of an assessment tool to measure behaviour change in sexualised drug use for substance use treatment studies. International Journal of Drug Policy. 55. 165–168. 2 indexed citations
10.
Rodgers, Craig. (2018). Brief interventions for alcohol and other drug use. Australian Prescriber. 41(4). 117–121. 7 indexed citations
11.
Day, Carolyn, Marian Shanahan, Handan Wand, et al.. (2015). Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial. Journal of Clinical Virology. 74. 66–72. 12 indexed citations
12.
Topp, Libby, Carolyn Day, Handan Wand, et al.. (2013). A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Preventive Medicine. 57(4). 297–303. 50 indexed citations
13.
Islam, M. Mofizul, Libby Topp, Katherine M. Conigrave, et al.. (2012). The reliability of sensitive information provided by injecting drug users in a clinical setting: Clinician-administered versus audio computer-assisted self-interviewing (ACASI). AIDS Care. 24(12). 1496–1503. 64 indexed citations
14.
Day, Carolyn, Bethany White, Gregory J. Dore, et al.. (2010). Hepatitis B virus among injecting drug users in Sydney, Australia: Prevalence, vaccination and knowledge of status. Drug and Alcohol Dependence. 108(1-2). 134–137. 17 indexed citations
15.
Shearer, James, Marian Shanahan, Shane Darke, et al.. (2010). A cost‐effectiveness analysis of modafinil therapy for psychostimulant dependence. Drug and Alcohol Review. 29(3). 235–242. 12 indexed citations
16.
Shearer, James, Shane Darke, Craig Rodgers, et al.. (2009). A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction. 104(2). 224–233. 113 indexed citations
17.
Griffin, J.F.T., C.G. Mackintosh, & Craig Rodgers. (2005). Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis. Vaccine. 24(6). 835–845. 33 indexed citations
18.
Griffin, J.F.T., et al.. (2003). Diagnostic strategies and outcomes on three New Zealand deer farms with severe outbreaks of bovine tuberculosis. Tuberculosis. 84(5). 293–302. 20 indexed citations
19.
Griffin, J.F.T., et al.. (2001). Optimal models to evaluate the protective efficacy of tuberculosis vaccines. Tuberculosis. 81(1-2). 133–139. 33 indexed citations
20.
Griffin, John F., et al.. (1994). Diagnosis of tuberculosis due to Mycobacterium bovis in New Zealand red deer (Cervus elaphus) using a composite blood test and antibody assays. New Zealand Veterinary Journal. 42(5). 173–179. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allen McCutchan Breakdown of academic impact, for papers by Reena H. Doshi Breakdown of academic impact, for papers by Lin Pang Breakdown of academic impact, for papers by Pasquale Noto Breakdown of academic impact, for papers by Merimaaria Espo Breakdown of academic impact, for papers by Margareta Eriksson Breakdown of academic impact, for papers by Matthew Onorato Breakdown of academic impact, for papers by A. Vaglia Breakdown of academic impact, for papers by Jonathan Worth Breakdown of academic impact, for papers by Des Jarlais
Rankless by CCL
2026